OCRELIZUMAB THERAPY IN PATIENTS WITH ANTI-HBC ANTIBODIES - A PRELIMINARY STUDY.
Pol Merkur Lekarski
; 51(3): 189-193, 2023.
Article
in En
| MEDLINE
| ID: mdl-37589101
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Virus Activation
/
Antibodies, Monoclonal, Humanized
/
Hepatitis B
/
Multiple Sclerosis
Limits:
Humans
Language:
En
Journal:
Pol Merkur Lekarski
Journal subject:
MEDICINA
Year:
2023
Document type:
Article
Affiliation country:
Polonia
Country of publication:
Polonia